Related Experiment Videos
Insulin-like growth factor 1 expression in thyroid tumors
E Maiorano1, A Ciampolillo, G Viale
1Istituto di Anatomia Patologica, Università degli Studi di Bari, Italy. emaiorano@anatopat.uniba.it
Applied Immunohistochemistry & Molecular Morphology : AIMM
|August 11, 2000
Summary
Insulin-like growth factor 1 (IGF-1) and its receptor are elevated in thyroid tumors, suggesting a role in thyroid cancer development. Higher levels correlate with larger tumor size and local spread, indicating potential clinical implications.
Area of Science:
- Endocrinology
- Oncology
- Molecular Biology
Background:
- Insulin-like growth factor 1 (IGF-1) is implicated in thyrocyte proliferation through autocrine signaling.
- Limited in vivo data exist regarding IGF-1 expression in thyroid neoplasms.
Purpose of the Study:
- To investigate the in vivo expression of IGF-1 and its receptor (IGF-1rec) at both protein and mRNA levels in normal and neoplastic thyroid tissues.
- To correlate IGF-1 and IGF-1rec expression with clinicopathological features of thyroid adenomas and carcinomas.
Main Methods:
- Immunohistochemical analysis of IGF-1 and IGF-1rec in 50 thyroid adenomas and 53 thyroid carcinomas, compared to normal thyroid tissue.
- Quantitative assessment of IGF-1 mRNA expression in neoplastic tissues.
- Correlation of immunoreactivity with tumor size, intrathyroidal extension, patient demographics, tumor stage, and lymph node metastasis.
Main Results:
- Significantly increased IGF-1 and IGF-1rec immunoreactivity were observed in both adenomas and carcinomas compared to normal thyroid tissue.
- IGF-1 mRNA was upregulated in carcinomas but downregulated in adenomas.
- IGF-1 and IGF-1rec immunoreactivity positively correlated with tumor diameter and intrathyroidal extension, but not with other clinicopathological parameters.
Conclusions:
- The IGF-1 system likely plays a role in thyroid tumorigenesis, supporting in vitro findings.
- IGF-1 and IGF-1rec expression levels may serve as indicators of tumor aggressiveness and have potential clinical implications in thyroid cancer management.